Hansoh Pharma refiles Hong Kong IPO
Hansoh Pharmaceutical Group has refiled its long-anticipated Hong Kong IPO. The Chinese drug maker first planned to go public in 2016, and was said to be readying a roadshow for its IPO as recently as February.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: